lower risk – Page 19 – Communicable Diseases Research

Prophylactic Role of Ivermectin in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers

Preventive Medicine

Published on 2021-08-052022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 95% CI acute respiratory syndrome adjusted relative risk adverse events Care Chemoprophylaxis cohort study conducted coronavirus coronavirus 2 coronavirus disease COVID COVID-19 COVID-19 infection criteria diagnosed dose effective follow-up time Government of India HCW HCWs healthcare services healthcare worker Healthcare workers in vitro study India Infection investigated Ivermectin Kaplan-Meier lower risk maintain male Medical Science Mild pandemic participant participated polymerase chain Preventing Primary outcome Probability Prophylactic Prophylaxis prospective cohort study provided real-time reverse transcriptase reduced reported respiratory Result risk risk of COVID-19 risk reduction role SARS-CoV-2 SARS-COV-2 infection significantly lower single dose Symptom therapeutic Vaccine was used worker
[DOI] 10.7759/cureus.16897 PMC 바로가기 [Article Type] Preventive Medicine

Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study

Observational Study

Published on 2021-08-042022-10-05
Journal: Nicotine & tobacco research : official journal of [Category] SARS, 임상,

[키워드] 95% confidence interval age Analysis association attack rate Blood Group body mass index cause Clinical signs conducted coronavirus SARS-CoV-2 COVID-19 COVID-19 infection cross-sectional current had no Hospitalized Impact increased risk indicated Infection investigated IRB less lower risk mechanism median age Odds ratio outbreak paradoxical pathway Patient physiological polymerase chain recent reported Research retained risk SARS-CoV-2 SARS-CoV2 scale Seven severe disease Sex significantly lower smoker smoking smoking status Support susceptibility susceptible the disease Tobacco univariable analysis vessel
[DOI] 10.1093/ntr/ntab004 PMC 바로가기 [Article Type] Observational Study

Development of a framework for the implementation of synchronous e-mental health: a protocol for a realist synthesis of systematic reviews

동기 멘탈 건강의 구현을위한 프레임 워크 개발 : 체계적인 검토의 현실주의 합성을위한 프로토콜

Study Protocol

Published on 2021-08-032022-08-31
Journal: F1000Research [Category] Coronavirus, MERS, meta-analysis, SARS,

[키워드] Analysis approach Care CINAHL communication conducted COVID-19 pandemic database determine develop development EBM element evaluated Evidence facilitator finding framework grounded theory Health Health care health problems hypothese hypotheses identify implementation include Inference information integration Internet-Based Intervention Interpretation Intervention limitation lower risk Mental Disorders mental health mental health care mental health problem mental health professional Meta-analysis Online Systems protocol PsycINFO Qualitative qualitative research Remote Consultation subject synchronous systematic review systematic reviews Systematic Reviews as Topic Telemedicine Web of Science
[DOI] 10.12688/f1000research.27150.2 PMC 바로가기 [Article Type] Study Protocol

Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection

Case Report

Published on 2021-08-022022-10-28
Journal: Radiology Case Reports [Category] COVID-19,

Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States

Article

Published on 2021-08-012022-10-04
Journal: The International Journal on Drug Policy [Category] SARS, 신약개발,

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic

COVID-19 전염병 동안 간세포 암종의 감시 및 모니터링

Review

Published on 2021-08-012022-09-11
Journal: Clinical gastroenterology and hepatology : the off [Category] SARS, 바이오마커,

Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis

만성 투석 환자의 항체 상태, 질병 이력 및 SARS-CoV-2 감염 발생률

Observational Study

Published on 2021-08-012022-09-12
Journal: Journal of the American Society of Nephrology : JA [Category] MERS, SARS, 임상, 진단,

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update

COVID-19 환자에서 토실리주맙의 효능 및 안전성: 살아있는 체계적인 검토 및 메타 분석, 첫 번째 업데이트

Meta-Analysis

Published on 2021-08-012022-09-12
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 진단,

[키워드] 30-Day mortality 95%CI adjusted approach certainty of evidence citation Cohort concerning Controlled Corticosteroids COVID COVID-19 COVID-19 patients Daily death Efficacy eight elevated eligible evaluate evaluated Evidence examined Google higher risk hospitalized COVID-19 patients hospitalized patient IL-6 IL-6 receptor Infection interleukin-6 Intervention lower risk majority mechanical ventilation Meta-analysis moderate Mortality Multiorgan observational study Other outcome OVID participant Patient patients Placebo random effect Randomized controlled trial RCT RCTs RECOVERY trials reduce REMAP-CAP risk Risk of bias risk ratio RRs Secondary infection Serious Adverse Event Seven severe coronavirus disease severe COVID-19 Standard of care syndrome systematic review Tocilizumab Toxicity treat Treatment Web of Science
[DOI] 10.1016/j.cmi.2021.04.019 PMC 바로가기 [Article Type] Meta-Analysis

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

코로나19 폐렴으로 입원한 환자의 토파시티닙

Randomized Controlled Trial

Published on 2021-07-292022-09-11
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 임상, 치료제,

[키워드] 1:1 95% CI 95% confidence interval adverse event all-cause mortality assigned Brazil coronavirus disease Coronavirus disease 2019 COVID-19 pneumonia cumulative cumulative incidence death dose Efficacy and safety glucocorticoid Glucocorticoids hazard ratio hospital discharge Hospitalization Hospitalized incidence inhibitor Janus kinase Kinase inhibitor lower risk Mortality occurred Occurrence Ordinal Scale Patient patients hospitalized Pfizer Placebo placebo group Pneumonia Primary outcome randomization Randomly receive Respiratory failure risk risk ratio Serious Adverse Events STOP-COVID the patient the placebo group Tofacitinib
[DOI] 10.1056/NEJMoa2101643 PMC 바로가기 [Article Type] Randomized Controlled Trial

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Original Article

Published on 2021-07-282022-10-29
Journal: Journal of clinical hypertension (Greenwich, Conn. [Category] COVID-19, SARS,